Bevacizumab improves pathological response of colorectal cancer liver metastases treated with XELOX/FOLFOX. (Q43153223)

From Wikidata
Jump to navigation Jump to search
scientific article published on 23 February 2010
edit
Language Label Description Also known as
English
Bevacizumab improves pathological response of colorectal cancer liver metastases treated with XELOX/FOLFOX.
scientific article published on 23 February 2010

    Statements

    Bevacizumab improves pathological response of colorectal cancer liver metastases treated with XELOX/FOLFOX. (English)
    Markus Klinger
    Dietmar Tamandl
    Sandra Eipeldauer
    Beata Herberger
    Klaus Kaczirek
    Marion Dorfmeister
    Birgit Gruenberger
    Thomas Gruenberger
    23 February 2010
    2059-2065

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit